{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23311895",
  "DateCompleted": {
    "Year": "2013",
    "Month": "07",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "01",
        "Day": "14"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.3109/03009742.2012.739201"
    ],
    "Journal": {
      "ISSN": "1502-7732",
      "JournalIssue": {
        "Volume": "42",
        "Issue": "3",
        "PubDate": {
          "Year": "2013"
        }
      },
      "Title": "Scandinavian journal of rheumatology",
      "ISOAbbreviation": "Scand J Rheumatol"
    },
    "ArticleTitle": "Reactive arthritis following Salmonella infection: a population-based study.",
    "Pagination": {
      "StartPage": "196",
      "EndPage": "202",
      "MedlinePgn": "196-202"
    },
    "Abstract": {
      "AbstractText": [
        "To study the incidence and clinical picture of Salmonella-associated reactive arthritis (ReA), as well as other reactive musculoskeletal symptoms and the arthritogenicity of various Salmonella enterica ssp. enterica serotypes in the population.",
        "We sent a questionnaire on enteric and extraintestinal (especially musculoskeletal) symptoms to 999 consecutive subjects with a Salmonella-positive stool culture. Analysis of self-reported musculoskeletal symptoms was supplemented with a clinical examination of subjects with recent symptoms.",
        "Of the 999 Salmonella-positive subjects, 496 (50%) returned the questionnaire. Of these, 4.4% (22/496) had ReA and 13.7% (68/496) had other reactive musculoskeletal symptoms [tendinitis, enthesopathy, or bursitis (ReTe)]. Among the ReA patients, all adults, Salmonella Enteritidis was the most common causative serotype. The clinical picture of patients with ReA was mostly monoarticular or oligoarticular. Human leucocyte antigen (HLA)-B27 was positive in 42% of patients with ReA. The Salmonella O antigens of the 496 subjects belonged to eight groups (B, C, D1, E, G, I, L, and O), all with different major O antigenic determinants. All 22 patients with ReA and all 68 patients with ReTe were in O antigen groups B, C, D1, or E. However, the occurrence of musculoskeletal complications showed no statistically significant difference in relation to different O antigen groups (p = 0.69).",
        "ReA occurred in 4.4% of patients after Salmonella infection, with an annual incidence of 1.8/100,000 in Finland. We found no differences in arthritogenicity between different Salmonella serotypes that trigger musculoskeletal complications."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Rheumatology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. riitta.tuompo@hus.fi"
          }
        ],
        "LastName": "Tuompo",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hannu",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mattila",
        "ForeName": "L",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Siitonen",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Leirisalo-Repo",
        "ForeName": "M",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Scand J Rheumatol",
    "NlmUniqueID": "0321213",
    "ISSNLinking": "0300-9742"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "PHB2 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prohibitins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "microbiology"
      ],
      "DescriptorName": "Arthritis, Reactive"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Finland"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prohibitins"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Salmonella"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "epidemiology"
      ],
      "DescriptorName": "Salmonella Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Serotyping"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}